Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Mark J. Ratain

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Ratain, Mark J.

Item TypeName
Concept Academic Medical Centers
Concept Carcinoma, Renal Cell
Concept Ethics, Medical
Concept Economics, Medical
Concept Medical Records
Concept Societies, Medical
Concept Medical Oncology
Concept Renal Insufficiency, Chronic
Concept Schools, Medical
Concept Translational Medical Research
Concept Medical Order Entry Systems
Concept Pathology, Molecular
Concept Renal Insufficiency
Academic Article Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents.
Academic Article Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons.
Academic Article Study of cohort-specific consent and patient control in phase I cancer trials.
Academic Article Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.
Academic Article Granulocyte-macrophage--colony stimulating factor in metastatic renal cell carcinoma: a phase II trial.
Academic Article Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea.
Academic Article Conflict-of-interest policies.
Academic Article Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.
Academic Article A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863.
Academic Article Pentostatin pharmacokinetics and dosing recommendations in patients with mild renal impairment.
Academic Article Randomized discontinuation design: application to cytostatic antineoplastic agents.
Academic Article Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901.
Academic Article Phase II oncology trials: let's be positive.
Academic Article Clarification regarding "phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties" and the accompanying commentary, "phase II cancer trials: out of control?".
Academic Article Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.
Academic Article Genetic nondiscrimination legislation: a critical prerequisite for pharmacogenomics data sharing.
Academic Article Phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties.
Academic Article The value meal: how to save $1,700 per month or more on lapatinib.
Academic Article Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma.
Academic Article Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301.
Academic Article The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective.
Academic Article Testing the wrong hypothesis in phase II oncology trials: there is a better alternative.
Academic Article Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101.
Academic Article Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials.
Academic Article A phase I study of sirolimus and bevacizumab in patients with advanced malignancies.
Academic Article Recommended changes to oncology clinical trial design: revolution or evolution?
Academic Article Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.
Academic Article The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics.
Academic Article Value-based insurance design: aligning incentives, benefits, and evidence in oncology.
Academic Article Pharmacogenomics and patient care: one size does not fit all.
Academic Article Analysis of the yield of phase II combination therapy trials in medical oncology.
Academic Article Perceptions of cancer patients and their physicians involved in phase I trials.
Academic Article Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer.
Academic Article Body surface area as a determinant of pharmacokinetics and drug dosing.
Academic Article Skeletal complications in hairy cell leukemia: diagnosis and therapy.
Academic Article A novel fully automated molecular diagnostic system (AMDS) for colorectal cancer mutation detection.
Academic Article Estimation of renal cell carcinoma treatment effects from disease progression modeling.
Academic Article Identification of a variant in KDR associated with serum VEGFR2 and pharmacodynamics of Pazopanib.
Academic Article Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project".
Academic Article User beware: we need more science and less art when measuring financial toxicity in oncology.
Academic Article The impact of industry on oncology research and practice.
Academic Article Harmonization of Renal Function Assessment Is Needed During Early Clinical Development of Oncology Drugs.
Academic Article The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
Academic Article Final findings from a phase II, placebo-controlled, randomized discontinuation trial (RDT) of sorafenib (BAY 43-9006) in patients with advanced renal cell carcinoma (RCC).
Academic Article Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
Academic Article Essential Characteristics of Pharmacogenomics Study Publications.
Academic Article Enhancing the Visibility and Prestige of Clinical Pharmacology as a Medical Subspecialty.
Academic Article Ethical Framework for Including Research Biopsies in Oncology Clinical Trials: American Society of Clinical Oncology Research Statement.

Search Criteria
  • Medical
  • Renal
  • Pathology